BIOVIE INC. Quarterly Operating Income (Loss) in USD from Q3 2015 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Biovie Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2015 to Q3 2024.
  • Biovie Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$4.12M, a 62.1% increase year-over-year.
  • Biovie Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$25.4M, a 46% increase year-over-year.
  • Biovie Inc. annual Operating Income (Loss) for 2024 was -$32.2M, a 28.6% increase from 2023.
  • Biovie Inc. annual Operating Income (Loss) for 2023 was -$45.1M, a 65.4% decline from 2022.
  • Biovie Inc. annual Operating Income (Loss) for 2022 was -$27.3M, a 80.3% increase from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$25.4M -$4.12M +$6.75M +62.1% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 -$32.2M -$4.79M +$6.19M +56.4% Apr 1, 2024 Jun 30, 2024 10-K 2024-09-30
Q1 2024 -$38.4M -$7.73M +$6.04M +43.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 -$44.4M -$8.78M +$2.71M +23.6% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-13
Q3 2023 -$47.1M -$10.9M -$2.04M -23.1% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 -$45.1M -$11M -$1.68M -18.1% Apr 1, 2023 Jun 30, 2023 10-K 2024-09-30
Q1 2023 -$43.4M -$13.8M -$8.03M -140% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 -$35.4M -$11.5M -$4.83M -72.5% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-13
Q3 2022 -$30.5M -$8.83M -$3.29M -59.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 -$27.3M -$9.29M +$122M +92.9% Apr 1, 2022 Jun 30, 2022 10-K 2023-08-16
Q1 2022 -$150M -$5.75M -$2.75M -91.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 -$147M -$6.67M -$3.6M -118% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-10
Q3 2021 -$143M -$5.55M -$5.16M -1334% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 -$138M -$132M -$131M -22709% Apr 1, 2021 Jun 30, 2021 10-K 2022-09-27
Q1 2021 -$7.03M -$3M -$2.3M -329% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q4 2020 -$4.73M -$3.06M -$2.35M -331% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-08
Q3 2020 -$2.37M -$387K +$319K +45.2% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$2.69M -$577K +$79K +12% Apr 1, 2020 Jun 30, 2020 10-K 2021-08-30
Q1 2020 -$2.77M -$699K +$149K +17.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 -$2.92M -$710K -$210K -41.8% Oct 1, 2019 Dec 31, 2019 10-Q 2021-01-29
Q3 2019 -$2.71M -$706K -$215K -43.7% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 -$2.5M -$656K -$132K -25.2% Apr 1, 2019 Jun 30, 2019 10-K/A 2020-08-07
Q1 2019 -$2.36M -$848K -$157K -22.7% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
Q4 2018 -$2.21M -$501K -$6.06K -1.23% Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-13
Q3 2018 -$2.2M -$491K +$171K +25.8% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-19
Q2 2018 -$2.37M -$524K -$80K -18% Apr 1, 2018 Jun 30, 2018 10-K 2019-09-27
Q1 2018 -$2.29M -$691K -$291K -72.6% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 -$2M -$495K -$137K -38.3% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-12
Q3 2017 -$1.86M -$662K -$311K -88.5% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$1.55M -$444K -$174K -64.7% Apr 1, 2017 Jun 30, 2017 10-K 2018-10-05
Q1 2017 -$1.38M -$401K -$343K -592% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-14
Q4 2016 -$1.04M -$358K -$308K -617% Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-14
Q3 2016 -$729K -$351K -$297K -543% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 -$432K -$270K Apr 1, 2016 Jun 30, 2016 10-K 2017-08-24
Q1 2016 -$57.9K Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q4 2015 -$49.9K Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-07
Q3 2015 -$54.6K Jul 1, 2015 Sep 30, 2015 10-Q/A 2017-01-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.